HIV vaccine trial raises hopes of developing world
The first vaccine targeting the strains of HIV prevalent in sub-Saharan Africa and Asia, where millions of people are infected with the virus, has started Phase I volunteer studies in the USA.
Archives for August 6, 2003
LION sells compound library to Norak
LION bioscience of Germany has sold a compound library consisting of more than 500,000 diverse compounds to US company Norak Biosciences.
Scancell, Celltech team up on new cancer target
Scancell and Celltech are to collaborate on the development of novel monoclonal antibody therapeutics targeting Lewis y/b, a new cancer target.
Roche takes crystal-clear route to development
Swiss drugmaker Roche has succeeded in developing a crystalline form of one of its pipeline compounds with the help of a US company, TransForm Pharmaceuticals, that is applying a high-throughput approach to form and formulation.
High throughput ion channel screening
Swedish biotech tools company Cellectricon says it has now received orders from three of the top five pharmaceutical companies for its Dynaflow microfluidic chip technology for increasing productivity in the drug discovery process.
Researchers unravel LacY web
An Anglo-US team of researchers has unveiled the first structure of a membrane transport protein; disruptions in the activity of MTPs are involved in a number of diseases.